Kazakhstan vs Syrian Arab Republic: Deaths from pneumonia
Kazakhstan
2,811 deaths
in 2021
Syrian Arab Republic
2,665 deaths
in 2021
Kazakhstan rank
89th
Syrian Arab Republic rank
91st
Deaths from pneumonia over time
- Kazakhstan
- Syrian Arab Republic
How they compare
Kazakhstan currently reports 2,811 deaths against 2,665 deaths in Syrian Arab Republic, a difference of 146 deaths.
That makes Kazakhstan's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Kazakhstan ahead.
Kazakhstan ranks 89th and Syrian Arab Republic ranks 91st of 194 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 2 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | Kazakhstan | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,412 deaths | 2,523 deaths | 888.79 deaths | Kazakhstan |
| 2010s | 3,301 deaths | 4,302 deaths | 1,001 deaths | Syrian Arab Republic |
| 2020s | 3,094 deaths | 2,723 deaths | 370.77 deaths | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from pneumonia, Kazakhstan or Syrian Arab Republic?
- Kazakhstan, at 2,811 deaths against 2,665 deaths in Syrian Arab Republic as of 2021.
- What is the difference in deaths from pneumonia between Kazakhstan and Syrian Arab Republic?
- 146 deaths, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Syrian Arab Republic?
- 22 years are reported by both, from 2000 to 2021.
- How do Kazakhstan and Syrian Arab Republic rank globally for deaths from pneumonia?
- Kazakhstan ranks 89th and Syrian Arab Republic ranks 91st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from pneumonia. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from lower respiratory infections in both sexes.